difficile, small intestine bacterial overgrowth (SIBO), or inflammatory bowel disease (IBF)
Semaglutide is not a reportable compound in this system, regardless of how frequently you test positive random selection
However, medication should be paired with nutrition and lifestyle steps that improve insulin sensitivity, such as protein-forward meals, reduced ultra-processed food intake, strength training, walking after meals, sleep improvement, and stress reduction
SeekPeptides has put together this comprehensive breakdown so you can understand exactly what Qsymia is, what GLP-1 medications are, and how they compare across every metric that matters
11.1 What GLP-1 Therapy Does Not Do Current evidence does not support the claim that GLP-1 receptor agonists: Cause universal micronutrient depletion Directly impair intestinal absorption Mimic bariatric malabsorption Require blanket supplementation Intestinal anatomy remains intact